MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin

Author:

Shaw Dipika1,Singh Shreya1,Dogra Sunil2,Jayaraman Jyothi3,Bhat Ramesh3,Panda Saumya4,Chakrabarti Arunaloke1,Anjum Nishat5,Chowdappa Aruna6,Nagamoti Mahantesh6,Varshney Umesh5,Vanam Hari Pankaj7,Savio Jayanthi8,Antony Meryl9,Rudramurthy Shivaprakash M.1ORCID

Affiliation:

1. Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

2. Departments of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

3. Department of Dermatology, Venereology and Leprosy, Father Muller Medical College, Mangalore, Karnataka, India

4. Department of Dermatology, KPC Medical College, Kolkata, West Bengal, India

5. Department of Microbiology, Government Medical College Haldwani, Nainital, Uttarakhand, India

6. Department of Microbiology, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India

7. Department of Microbiology, Bhaskar Medical College & General Hospital, Haidarabad, Telangana, India

8. Department of Microbiology, St. John’s Medical College & Hospital, Bangalore, Karnataka, India

9. Department of Dermatology, St. John’s Medical College & Hospital, Bangalore, Karnataka, India

Abstract

Dermatophytosis due to the Trichophyton mentagrophytes-Trichophyton interdigitale complex is being increasingly reported across India. Reports of therapeutic failure have surfaced recently, but there are no clinical break points (CBP) or epidemiological cutoffs (ECVs) available to guide the treatment of dermatophytosis. In this study, a total of 498 isolates of the T. mentagrophytes -interdigitale complex were collected from six medical centers over a period of five years (2014 to 2018).

Funder

Indian Association of Dermatologist Venerologists and Leprologists

Indian Council of Medical Research

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3